The European Union strongly endorses the work of the African Union Development Agency-NEPAD (AUDA-NEPAD) to strengthen medicines regulators and improve health security on the African continent. The European Union, including the European Commission, the European Medicines Agency (EMA), and EU Member States Belgium, France and Germany, and the Bill & Melinda Gates Foundation will mobilise more than €100 million over the next five years to support the recently established African Medicines Agency (AMA) and other African medicines regulatory initiatives at regional and national levels. This support to strengthening regulatory capacity will improve health security in Africa, including through the expansion of local manufacturing of quality, safe, efficacious, and affordable medicines, vaccines, and other health tools. The commitments announced today will support the first stages of the continent-wide African Medicines Agency and the further development of African medicines regulatory capacity at regional and national levels. This funding intends to foster collaboration and sharing of technical expertise between the EMA and the AMA and support several African national regulatory authorities to achieve the minimum World Health Organization requirements for effective regulatory oversight for quality local vaccine production. Read the full press release here.
Share this article:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter.
